Literature DB >> 22595319

Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia.

Lori B Daniels1, Matthew S Tjajadi, Hannah H Walford, Susan Jimenez-Fernandez, Vera Trofimenko, Daryl B Fick, Hoang-Anh L Phan, Peter E Linz, Keshav Nayak, Andrew M Kahn, Jane C Burns, John B Gordon.   

Abstract

BACKGROUND: Up to 25% of patients with untreated Kawasaki disease (KD) and 5% of those treated with intravenous immunoglobulin will develop coronary artery aneurysms. Persistent aneurysms may remain silent until later in life when myocardial ischemia can occur. We sought to determine the prevalence of coronary artery aneurysms suggesting a history of KD among young adults undergoing coronary angiography for evaluation of possible myocardial ischemia. METHODS AND
RESULTS: We reviewed the medical histories and coronary angiograms of all adults <40 years of age who underwent coronary angiography for evaluation of suspected myocardial ischemia at 4 San Diego hospitals from 2005 to 2009 (n=261). History of KD-compatible illness and cardiac risk factors were obtained by medical record review. Angiograms were independently reviewed for the presence, size, and location of aneurysms and coronary artery disease by 2 cardiologists blinded to the history. Patients were evaluated for number of risk factors, angiographic appearance of their coronary arteries, and known history of KD. Of the 261 young adults who underwent angiography, 16 had coronary aneurysms. After all clinical criteria were assessed, 5.0% had aneurysms definitely (n=4) or presumed (n=9) secondary to KD as the cause of their coronary disease.
CONCLUSIONS: Coronary sequelae of KD are present in 5% of young adults evaluated by angiography for myocardial ischemia. Cardiologists should be aware of this special subset of patients who may benefit from medical and invasive management strategies that differ from the strategies used to treat atherosclerotic coronary artery disease.

Entities:  

Mesh:

Year:  2012        PMID: 22595319      PMCID: PMC3393523          DOI: 10.1161/CIRCULATIONAHA.111.082107

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

1.  Rotational ablation and stent placement for severe calcific coronary artery stenosis after Kawasaki disease.

Authors:  Thomas F Peters; Sanjay R Parikh; Cass A Pinkerton
Journal:  Catheter Cardiovasc Interv       Date:  2002-08       Impact factor: 2.692

Review 2.  Long-term outcome of Kawasaki disease.

Authors:  Hideaki Senzaki
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

Review 3.  Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings.

Authors:  A Suzuki; S Miyagawa-Tomita; M Nakazawa; C Yutani
Journal:  Jpn Heart J       Date:  2000-05

4.  Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study.

Authors:  A Suzuki; S Miyagawa-Tomita; K Komatsu; T Nishikawa; Y Sakomura; T Horie; M Nakazawa
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 5.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

6.  Spatial and temporal clustering of Kawasaki syndrome cases.

Authors:  Annie S Kao; Arthur Getis; Stephanie Brodine; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

7.  Resistance to intravenous immunoglobulin in children with Kawasaki disease.

Authors:  Adriana H Tremoulet; Brookie M Best; Sungchan Song; Susan Wang; Elena Corinaldesi; Julia R Eichenfield; Danielle D Martin; Jane W Newburger; Jane C Burns
Journal:  J Pediatr       Date:  2008-03-04       Impact factor: 4.406

8.  Increasing incidence of Kawasaki disease in Japan: nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Izumi Oki; Kazunori Kayaba; Hiroshi Yanagawa
Journal:  Pediatr Int       Date:  2008-06       Impact factor: 1.524

9.  Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease.

Authors:  Kenji Suda; Yoshiyuki Kudo; Takashi Higaki; Yuichi Nomura; Masaru Miura; Masahiko Matsumura; Mamoru Ayusawa; Shunichi Ogawa; Toyojiro Matsuishi
Journal:  Circ J       Date:  2009-05-12       Impact factor: 2.993

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Izumi Chihara; Yasuko Aoyama; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2010-06-05       Impact factor: 3.211

View more
  35 in total

1.  Coronary artery disease: Consider Kawasaki disease when assessing myocardial ischemia.

Authors:  Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2012-06-05       Impact factor: 32.419

2.  Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Daniel Phadke; Sonali S Patel; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glode; Pei-Ni Jone
Journal:  Pediatr Cardiol       Date:  2015-05-21       Impact factor: 1.655

3.  Acute myocardial infarction in a 35-year-old man with coronary artery aneurysm most probably caused by Kawasaki disease.

Authors:  Saeed Alipour Parsa; Isa Khaheshi; Koosha Paydary; Habib Haybar
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

4.  Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood.

Authors:  Sherif R Y Rizk; Galal El Said; Lori B Daniels; Jane C Burns; Howaida El Said; Khaled A Sorour; Soliman Gharib; John B Gordon
Journal:  Am J Cardiol       Date:  2014-11-29       Impact factor: 2.778

5.  Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood.

Authors:  Chisato Shimizu; Alka Sood; Hubert D Lau; Toshiaki Oharaseki; Kei Takahashi; Henry F Krous; Steven Campman; Jane C Burns
Journal:  Cardiovasc Pathol       Date:  2015-02-24       Impact factor: 2.185

6.  Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin.

Authors:  Adriana H Tremoulet; Sonia Jain; Jane C Burns
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-13       Impact factor: 0.694

7.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

8.  Coronary Artery Complications in Pediatric Patients with Kawasaki Disease: A 12-Year National Survey.

Authors:  Chun-Yen Chiang; Chung-Han Ho; Chin-Chen Chu; Zhih-Cherng Chen; Jhi-Joung Wang; Yung-Zu Tseng
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

9.  High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease.

Authors:  Yung-Chuan Chen; Ching-Tsuen Shen; Nan-Koong Wang; Yi-Ling Huang; Hsin-Hui Chiu; Chun-An Chen; Shuenn-Nan Chiu; Ming-Tai Lin; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

10.  ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge.

Authors:  Elizabeth L Potter; Ian T Meredith; Peter James Psaltis
Journal:  BMJ Case Rep       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.